Chemical manufacturers seeking alternatives to banned compounds may have created a new endocrine disruption problem. At concentrations matching those found in children's blood, a fluorinated chemical used as a PFOS replacement triggers excessive thyroid hormone production in human thyroid cells—an effect that contradicts animal studies suggesting the opposite outcome.
The chlorinated polyfluoroalkyl ether sulfonic acid (Cl-PFESA or F-53B) activated the master thyroid transcription factor PAX8, leading to increased production of thyroxine and triiodothyronine in cultured human thyroid follicular cells. This activation upregulated key thyroid proteins including thyroglobulin and thyroid peroxidase while simultaneously reducing the sodium iodide symporter that brings iodine into cells. When researchers knocked down PAX8 expression, they completely eliminated the hormone-boosting effect, confirming this pathway's central role. Notably, iodide levels influenced the response in complex ways: moderate iodide concentrations amplified hormone overproduction, while very high levels suppressed it.
This finding highlights a critical gap in chemical safety assessment—animal models may not predict human thyroid responses to industrial pollutants. The hyperthyroid effect observed in human cells contrasts sharply with hypothyroid outcomes reported in animal studies of the same compound. For adults concerned about endocrine health, this research underscores how ostensibly "safer" chemical alternatives can carry unforeseen risks. The thyroid's sensitivity to environmental chemicals, combined with the complex interplay between pollutant exposure and nutritional iodine status, suggests that regulatory frameworks may need updating to better protect human thyroid function in an increasingly contaminated world.